Artesunate inhibits the growth and induces apoptosis of human gastric cancer cells by downregulating COX-2
- PMID: 25945055
- PMCID: PMC4406257
- DOI: 10.2147/OTT.S81041
Artesunate inhibits the growth and induces apoptosis of human gastric cancer cells by downregulating COX-2
Abstract
Artesunate, a derivative of artemisinin isolated from Artemisia annua L., has been traditionally used to treat malaria, and artesunate has demonstrated cytotoxic effects against a variety of cancer cells. However, there is little available information about the antitumor effects of artesunate on human gastric cancer cells. In the present study, we investigated the antitumor effect of artesunate on human gastric cancer cells and whether its antitumor effect is associated with reduction in COX-2 expression. The effects of artesunate on the growth and apoptosis of gastric cancer cells were investigated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, flow cytometric analysis of annexin V-fluorescein isothiocyanate/propidium iodide staining, rhodamine 123 staining, and Western blot analysis. Results indicate that artesunate exhibits antiproliferative effects and apoptosis-inducing activities. Artesunate markedly inhibited gastric cancer cell proliferation in a time- and dose-dependent manner and induced apoptosis in gastric cancer cells a dose-dependent manner, which was associated with a reduction in COX-2 expression. Treatment with the selective COX-2 inhibitor celecoxib, or transient transfection of gastric cancer cells with COX-2 siRNA, also inhibited cell proliferation and induced apoptosis. Furthermore, the treatment with artesunate promoted the expression of proapoptotic factor Bax and suppressed the expression of antiapoptotic factor Bcl-2. In addition, caspase-3 and caspase-9 were activated, and artesunate induced loss of mitochondrial membrane potential, suggesting that the apoptosis is mediated by mitochondrial pathways. These results demonstrate that artesunate has an effect on anti-gastric cancer cells. One of the antitumor mechanisms of artesunate may be that its inhibition of COX-2 led to reduced proliferation and induction of apoptosis, connected with mitochondrial dysfunction. Artesunate might be a potential therapeutic agent for gastric cancer.
Keywords: COX-2; apoptosis; artesunate; gastric cancer cells.
Figures
Similar articles
-
Artesunate induces apoptosis through caspase-dependent and -independent mitochondrial pathways in human myelodysplastic syndrome SKM-1 cells.Chem Biol Interact. 2014 Aug 5;219:28-36. doi: 10.1016/j.cbi.2014.03.011. Epub 2014 Apr 3. Chem Biol Interact. 2014. PMID: 24704559
-
Danthron, an anthraquinone derivative, induces DNA damage and caspase cascades-mediated apoptosis in SNU-1 human gastric cancer cells through mitochondrial permeability transition pores and Bax-triggered pathways.Chem Res Toxicol. 2011 Jan 14;24(1):20-9. doi: 10.1021/tx100248s. Epub 2010 Dec 2. Chem Res Toxicol. 2011. PMID: 21126053
-
Paeonol exerts an anticancer effect on human colorectal cancer cells through inhibition of PGE₂ synthesis and COX-2 expression.Oncol Rep. 2014 Dec;32(6):2845-53. doi: 10.3892/or.2014.3543. Epub 2014 Oct 13. Oncol Rep. 2014. PMID: 25322760
-
Pseudolaric acid B exerts antitumor activity via suppression of the Akt signaling pathway in HeLa cervical cancer cells.Mol Med Rep. 2015 Aug;12(2):2021-6. doi: 10.3892/mmr.2015.3615. Epub 2015 Apr 15. Mol Med Rep. 2015. PMID: 25891953
-
Progress on the study of the anticancer effects of artesunate.Oncol Lett. 2021 Nov;22(5):750. doi: 10.3892/ol.2021.13011. Epub 2021 Aug 27. Oncol Lett. 2021. PMID: 34539854 Free PMC article. Review.
Cited by
-
Antineoplastic Drug Synergy of Artesunate with Navitoclax in Models of High-Grade Serous Ovarian Cancer.Cancers (Basel). 2024 Mar 28;16(7):1321. doi: 10.3390/cancers16071321. Cancers (Basel). 2024. PMID: 38610999 Free PMC article.
-
YM155, specific survivin inhibitor, can enhance artesunate-induced cytotoxicity in HCT116 colon cancer cells.Korean J Clin Oncol. 2020 Dec;16(2):131-137. doi: 10.14216/kjco.20020. Epub 2020 Dec 31. Korean J Clin Oncol. 2020. PMID: 36945719 Free PMC article.
-
The roles of COX-2 in protozoan infection.Front Immunol. 2023 Feb 16;14:955616. doi: 10.3389/fimmu.2023.955616. eCollection 2023. Front Immunol. 2023. PMID: 36875123 Free PMC article. Review.
-
Shikonin Inhibits Cell Growth of Sunitinib-Resistant Renal Cell Carcinoma by Activating the Necrosome Complex and Inhibiting the AKT/mTOR Signaling Pathway.Cancers (Basel). 2022 Feb 22;14(5):1114. doi: 10.3390/cancers14051114. Cancers (Basel). 2022. PMID: 35267423 Free PMC article.
-
Artemisinins in Combating Viral Infections Like SARS-CoV-2, Inflammation and Cancers and Options to Meet Increased Global Demand.Front Plant Sci. 2022 Feb 7;13:780257. doi: 10.3389/fpls.2022.780257. eCollection 2022. Front Plant Sci. 2022. PMID: 35197994 Free PMC article. Review.
References
-
- Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63(1):11–30. - PubMed
-
- Bornschein J, Rokkas T, Selgrad M, Malfertheiner P. Gastric cancer: clinical aspects, epidemiology and molecular background. Helicobacter. 2011;16(Suppl 1):45–52. - PubMed
-
- Méric JB, Rottey S, Olaussen K, et al. Cyclooxygenase-2 as a target for anticancer drug development. Crit Rev Oncol Hematol. 2006;59(1):51–64. - PubMed
-
- Riedl K, Krysan K, Põld M, et al. Multifaceted roles of cyclooxygenase-2 in lung cancer. Drug Resist Updat. 2004;7(3):169–184. - PubMed
-
- Tucker ON, Dannenberg AJ, Yang EK, et al. Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer. Cancer Res. 1999;59(5):987–990. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials